Hospitals and providers who diagnose or provide treatment of sickle cell disease and its variants must report information regarding patients, including usage of and access to health care services.
If the examination and tests reveal the existence of preventable/inheritable disorders or conditions in an infant, the provider or hospital attending or assisting at the birth of the infant shall report to the State's Chief Medical Officer, and local county health officers. Upon notification by the State Public Health Laboratory that a test is abnormal or questionable, the child’s physician or the person who is legally responsible for registering the birth of the child shall cause to have taken an additional blood sample and any additional tests which are required to evaluate the possible abnormality and shall report that action to the State Public Health Laboratory. A hospital or obstetric center shall complete a newborn screening collection form obtained from the State Public Health Laboratory if a blood sample is not taken from an infant before his or her discharge from the hospital or obstetric center, unless the infant is transferred to a hospital that provides a higher level of neonatal care. The hospital or obstetric center shall send the newborn screening collection form indicating that a blood sample was not taken from an infant to the State Public Health Laboratory within 2 working days after the infant is discharged from the hospital or obstetric center.